anemia

Akebia CEO John Butler
Pharma

Akebia drops Vafseo trial, failing to get 'alignment' with FDA

Akebia has scrapped plans for a trial that would have potentially led to an expansion of the patient population for its new anemia drug Vafseo.
Kevin Dunleavy Oct 29, 2025 11:31am
Graphic of a drop of blood made up of small data points and nodes

CSL's Venofer finally faces generic competition

Aug 13, 2025 2:06pm
BMS

Bristol Myers' clinical woes deepen with failed Reblozyl ph. 3

Jul 18, 2025 11:28am
expansion milestones advance advancing progress

Akebia sketches out pivotal Vafseo study in nondialysis patients

Mar 13, 2025 3:28pm
Antitrust suit

CSL Vifor promises marketing campaign to resolve EU probe

Jul 22, 2024 11:18am
Patient monitored by electronic sphygmomanometer during dialysis session Advanced dialysis equipment in hospital

After high-profile snub, Akebia plots vadadustat resubmission

Aug 24, 2023 10:40am